Key Findings
- Systolic blood pressure was reduced by an average of 3.5 mmHg with resveratrol supplementation
- Flow-mediated dilation (FMD) improved by 1.5%, indicating better endothelial function
- LDL cholesterol showed modest reductions in participants with elevated baseline levels
- CRP and IL-6 inflammatory markers decreased in trials lasting 8+ weeks
- Bioavailability remains a challenge — formulations with enhanced absorption showed stronger effects